These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 29364331)
1. Is HCV elimination possible in prison? Crespo J; Llerena S; Cobo C; Cabezas J Rev Esp Sanid Penit; 2017 Dec; 19(3):70-73. PubMed ID: 29364331 [No Abstract] [Full Text] [Related]
2. People living in prison must be included in country monitoring systems to accurately assess HCV elimination progress. Tavoschi L; Cocco N; Alves da Costa F; Lloyd AR; Kinner SA Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):500-501. PubMed ID: 38734003 [No Abstract] [Full Text] [Related]
3. [Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain]. Martín Sánchez V; Ferrer Castro V; Pallas Álvarez JR; Alonso Herrero LE; Andrés Honorato M; Coterillo González MJ; García Marcos LS; González Márquez J; Hernández Alonso I; LLanos Gallegos M; Mallada García E; Martínez Martínez ML; Morillo Pérez M; Pérez Martínez I; Valles Martínez J Rev Esp Salud Publica; 1998; 72(1):43-51. PubMed ID: 9477715 [TBL] [Abstract][Full Text] [Related]
4. HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons. Flisiak R; Zarębska-Michaluk D; Ciupkeviciene E; Drazilova S; Frankova S; Grgurevic I; Hunyady B; Jarcuska P; Kupčinskas L; Makara M; Saulite-Vanaga G; Simonova M; Sperl J; Tolmane I; Vince A Viruses; 2022 Feb; 14(3):. PubMed ID: 35336889 [TBL] [Abstract][Full Text] [Related]
5. Surveillance and prevention of hepatitis C in Australian prisons. Dolan K Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):68-9. PubMed ID: 11833205 [TBL] [Abstract][Full Text] [Related]
6. Presence of hepatitis C virus in syringes confiscated in prisons in Australia. Dolan K; Larney S; Jacka B; Rawlinson W J Gastroenterol Hepatol; 2009 Oct; 24(10):1655-7. PubMed ID: 19788605 [TBL] [Abstract][Full Text] [Related]
7. Treatment-as-prevention in prison settings: a growing evidence base for HCV elimination efforts. Tavoschi L Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):512-513. PubMed ID: 33965005 [No Abstract] [Full Text] [Related]
8. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH). Crespo J; Albillos A; Buti M; Calleja JL; García Samaniego J; Hernández Guerra M; Serrano T; Turnes J; Acín E; Berenguer J; Berenguer M; Colom J; Fernández I; Fernández Rodríguez C; Forns X; García F; Grandados R; Lazarus JV; Molero JM; Molina E; Pérez Escanilla F; Pineda JA; Rodríguez M; Romero M; Roncero C; Saiz de la Hoya P; Sánchez Antolín G Rev Esp Enferm Dig; 2019 Nov; 111(11):862-873. PubMed ID: 31657609 [TBL] [Abstract][Full Text] [Related]
9. Prisons and HCV: a review and a report on an experience in New South Wales Australia. Batey RG; Jones T; McAllister C Int J Prison Health; 2008; 4(3):156-63. PubMed ID: 18698530 [TBL] [Abstract][Full Text] [Related]
10. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons. He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252 [TBL] [Abstract][Full Text] [Related]
11. Seropositivity of hepatitis C in prison inmates of Pakistan--a cross sectional study in prisons of Sindh. Gorar ZA; Zulfikar I J Pak Med Assoc; 2010 Jun; 60(6):476-9. PubMed ID: 20527648 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of needle exchange program at Pereiro de Aguiar prison (Ourense, Spain): ten years of experience]. Ferrer-Castro V; Crespo-Leiro MR; García-Marcos LS; Pérez-Rivas M; Alonso-Conde A; García-Fernández I; Lorenzo-Guisado A; Sánchez-Fernández JL; Seara-Selas M; Sanjosé-Vallejo R Rev Esp Sanid Penit; 2012; 14(1):3-11. PubMed ID: 22437903 [TBL] [Abstract][Full Text] [Related]
13. Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH). Crespo J; Albillos A; Buti M; Calleja JL; García-Samaniego J; Hernández-Guerra M; Serrano T; Turnes J; Acín E; Berenguer J; Berenguer M; Colom J; Fernández I; Fernández Rodríguez C; Forns X; García F; Rafael Granados ; Lazarus JV; Molero JM; Molina E; Pérez Escanilla F; Pineda JA; Rodríguez M; Romero M; Roncero C; Saiz de la Hoya P; Sánchez Antolín G Gastroenterol Hepatol; 2019 Nov; 42(9):579-592. PubMed ID: 31594683 [TBL] [Abstract][Full Text] [Related]
14. [HIVAb, HCVAb and HBsAg seroprevalence among inmates of the prison of Bologna and the effect of counselling on the compliance of proposed tests]. Sabbatani S; Giuliani R; Fulgaro C; Paolillo P; Baldi E; Chiodo F Epidemiol Prev; 2004; 28(3):163-8. PubMed ID: 15532873 [TBL] [Abstract][Full Text] [Related]
15. Quick diagnosis, staging, and treatment of HCV infection among people living in prison: Opinion expert panel. Fiore V; De Matteis G; Pontali E; De Vito A; Panese S; Geremia N; Maida I; Artioli S; Starnini G; Madeddu G; Babudieri S Front Public Health; 2022; 10():926414. PubMed ID: 36268000 [No Abstract] [Full Text] [Related]
17. A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany. Stark K; Herrmann U; Ehrhardt S; Bienzle U Epidemiol Infect; 2006 Aug; 134(4):814-9. PubMed ID: 16371183 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C in Australian prisons: a national needs assessment. Mina MM; Herawati L; Butler T; Lloyd A Int J Prison Health; 2016; 12(1):3-16. PubMed ID: 26933988 [TBL] [Abstract][Full Text] [Related]
19. Prison puzzle: treating hepatitis C. Webster PC CMAJ; 2012 Jun; 184(9):1017-8. PubMed ID: 22566525 [No Abstract] [Full Text] [Related]
20. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study. Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J; J Viral Hepat; 2017 Sep; 24(9):733-741. PubMed ID: 28256027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]